Alignment Stock Surges After 2.48% Medicare Rate Hike
Alignment Healthcare (ALHC) stock surged after the U.S. government announced a 2.48% Medicare Advantage and Part D payment rate hike for 2027, with an effective increase closer to 5% due to risk-scoring adjustments. This reversal from an earlier flat reimbursement proposal is seen as a significant win for insurers, particularly as regulators also delayed certain risk-model changes. Technical analysis shows positive short-term and intermediate trends for ALHC, with analysts maintaining a Buy rating and increased price targets.
Alignment Healthcare, Centene, CVS Health, Elevance Health, and Clover Health Stocks Trade Up, What You Need To Know
Several health insurance provider stocks, including Alignment Healthcare, Centene, CVS Health, Elevance Health, and Clover Health, saw significant jumps after the government announced a surprise increase in Medicare Advantage payment rates. This change is expected to improve profit margins for these companies by increasing revenue from federal funds without raising costs. Alignment Healthcare, in particular, experienced an 18.7% jump, contributing to its 9.3% gain since the start of the year and bringing it close to its 52-week high.
UnitedHealth Jumps on CMS' MA Rate Boost: How to Position Now
The Centers for Medicare and Medicaid Services (CMS) finalized Medicare Advantage (MA) payment rates for 2027 with a 2.48% increase, significantly higher than the initial proposal, boosting health insurer stocks like UnitedHealth, Humana, and Centene. This decision alleviates some pressure on the managed care sector, which has faced declines due to rising utilization, cost pressures, and regulatory scrutiny. UnitedHealth, specifically, is well-positioned to benefit from this rate hike due to its scale and integrated Optum platform, despite facing near-term membership declines in pursuit of profitability.
CVS Stock Rises After CMS Medicare Advantage Update
CVS Health stock is up after the Centers for Medicare & Medicaid Services (CMS) announced an average 2.48% increase in Medicare Advantage payments for 2027, totaling over $13 billion. This update is significant for CVS due to its Aetna insurance unit and managed-care exposure, despite CMS maintaining the 2024 risk-adjustment model and excluding certain diagnoses from risk-score calculations. Investors are focusing on the funding boost ahead of the company's Q1 earnings report on May 6th, with analysts maintaining a bullish bias on the stock.
Health insurance stocks: UnitedHealth Group, CVS, and Humana are rising on Medicare Advantage news
Health insurance stocks, including those of UnitedHealth Group, Humana, and CVS Health, are increasing after the Trump administration decided to significantly raise Medicare insurer payments. This decision backtracks on an earlier, lower increase proposal and follows extensive lobbying from the private insurance industry. The revised plan means an additional $13 billion will be paid to private health insurers for Medicare Advantage in 2027, with a net average increase of 2.48%.
OpenAI, WHOOP gains lift SuRo Capital as Magnetar joins adviser plan
SuRo Capital announced a plan to transition to an externally managed structure through a joint venture with Magnetar, Neostellar Advisors LLC, aiming to enhance shareholder value and investment capabilities. The company also provided a preliminary Q1 2026 investment portfolio update, estimating its Net Asset Value (NAV) to be between $14.00 and $14.50 per share, largely due to strong performance in holdings such as OpenAI and WHOOP. This externalization, subject to stockholder approval, is expected to bring expense savings and preserve realized gains for stockholders.
Health insurers rise after US lifts 2027 Medicare Advantage payment rates
Shares of U.S. health insurers saw a significant climb after the government announced 2027 Medicare Advantage payment rates that exceeded expectations, resulting in over $13 billion in additional payments. This increase, averaging 2.48% for private insurers offering Medicare Advantage plans, was much higher than the initially proposed 0.09% rate. Analysts noted that these "better-than-feared" rates alleviate concerns about the industry's margins and make the sector more investable after a period of financial strain from rising medical costs.
Centene Corp. stock: Why it's drawing investor attention amid healthcare shifts
Centene Corp. is gaining investor attention due to a 4% stock increase following a rise in Medicare Advantage rates for 2027, signaling brighter prospects for the managed care giant. The article details Centene's business model focused on government-funded healthcare programs like Medicaid and Medicare, its competitive advantages in a fragmented market, and risks including regulatory changes and competition. Analysts hold a cautious "Hold" rating with potential upside, making it a defensive play for long-term investors.
5-Day Rally Sends Apellis Pharmaceuticals Stock Up 139%
Apellis Pharmaceuticals (APLS) experienced a 5-day winning streak, boosting its stock by 139% and increasing its market cap by $3.0 billion to $5.1 billion. Despite this surge, Trefis rates APLS stock as "Unattractive" due to its moderate operating performance, financial condition, and high valuation. The article provides a detailed comparison of APLS returns against the S&P 500 and highlights key financial metrics.
Live Nation Entertainment Stock 5-Day Winning Spree: Stock Climbs 9.9%
Live Nation Entertainment (LYV) has experienced a 5-day winning streak, with its stock climbing 9.9%, leading to a market cap increase of $3.3 billion to $37 billion. Despite this surge, Trefis rates LYV as "Unattractive" due to its moderate operating performance, financial condition, and high valuation. The article provides a detailed breakdown of LYV's returns compared to the S&P 500 and its recent financial metrics.
Insurance stocks jump on Medicare Advantage rate boost: Humana, UnitedHealth, lead gains (UNH:NYSE)
Insurance stocks, including Humana and UnitedHealth, saw increases after the Centers for Medicare & Medicaid Services (CMS) announced a 2.48% boost in average Medicare Advantage payments for 2027, totaling over $13 billion. This positive news led to gains for major insurance companies in after-hours trading.
New Medicare Payment Rate Released. Why UnitedHealth Stock Is Popping.
The federal government has announced a 2.48% average increase in Medicare payments to insurers for next year, a significant financial update for major health insurance companies. This news has led to a rise in UnitedHealth's stock. Medicare Advantage is a crucial business segment for these insurers, covering 35 million beneficiaries.
UnitedHealth, Humana, Health Insurers Jump On Higher Medicare Advantage Payments
UnitedHealth Group, Humana, and CVS Health saw their stock prices rise following an announcement by the Trump administration regarding higher-than-expected Medicare Advantage payment rates for 2027. The Centers for Medicare and Medicaid Services stated that rates would increase by 2.48%, totaling $13 billion, moving significantly upward from the proposed 0.09% gain announced in January. This positive adjustment in payment rates led to a jump in shares for these health insurers.
CNC Combines Its North Carolina Units to Expand Statewide Footprint
Centene Corporation (CNC) announced that its North Carolina subsidiaries, Carolina Complete Health and WellCare of North Carolina, will merge into a single provider-led managed care organization under the Carolina Complete Health brand. This merger aims to expand Centene's statewide presence and boost premium revenues by serving over 980,000 members across Medicaid, Medicare, and Marketplace plans, while also supporting Behavioral Health and I/DD Tailored Plans. The combined entity focuses on improving care coordination, access, and health outcomes through collaboration with local providers and enhancing value-added services.
Centene tumbles on ACA warnings but leads managed care with top buy quant rating
Centene's stock has fallen due to warnings regarding the Affordable Care Act (ACA), yet it maintains a leading "Buy" quant rating among managed care organizations. This indicates a discrepancy between market reaction and quantitative analysis for the company.
Centene tumbles on ACA warnings but leads managed care with top buy quant rating
Centene's stock has fallen due to concerns about Affordable Care Act (ACA) market profitability, with fears of increased medical loss ratios for 2025. Despite this, Centene maintains a "Strong Buy" quant rating and leads its managed care peers, reflecting underlying strengths even amid market volatility. The stock's performance highlights the challenges and opportunities within the evolving healthcare sector.
CNC Merges Its North Carolina Divisions to Broaden Presence Across the State
Centene Corporation (CNC) is unifying its North Carolina subsidiaries, Carolina Complete Health and WellCare of North Carolina, into a single managed care organization under the Carolina Complete Health name. This merger aims to enhance care coordination, streamline access, and improve health outcomes for over 980,000 individuals across Medicaid, Medicare, and Marketplace programs, while also strengthening Centene's financial performance through increased premium revenues. The combined entity will focus on community health initiatives including addressing food insecurity, supporting maternal health, and promoting preventive care.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Centene Corporation (CNC) And Encourages Shareholders to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Centene Corporation (NYSE:CNC). The investigation focuses on whether Centene and its officers engaged in corporate wrongdoing. Shareholders who purchased Centene securities before December 12, 2024, are encouraged to contact the firm for more information.
CNC PE Ratio & Valuation, Is CNC Overvalued
This article analyzes the valuation of Centene Corp (CNC), concluding that it is currently undervalued. Based on its forward PE ratio of 11.78 compared to a five-year average of 12.26, and a current price of $35.11 against a fair price range of $59.57 to $72.52, CNC is considered undervalued by 41.06%. The analysis also details its P/B ratio, FCF yield, and P/S ratio compared to industry averages and historical data.
How Investors May Respond To Acadia Healthcare (ACHC) Prioritizing Cash Flow And Existing Facilities Over Expansion
Acadia Healthcare (ACHC) is shifting its strategy to prioritize cash flow and optimize existing facilities, rather than focusing solely on expansion. The company expects positive free cash flow in 2026 due to moderated capital spending and joint ventures, which could improve its financial profile. Investors should consider this new focus in light of ongoing uncertainties regarding Medicaid reimbursement and state supplemental payments.
Aberdeen Group Reduces Emerson Electric Holdings
Aberdeen Group plc, an institutional investor, decreased its stake in Emerson Electric Co. by 1.7% in the fourth quarter, now holding 541,130 shares valued at approximately $71.82 million. This move, detailed in a recent SEC filing, indicates ongoing scrutiny by major funds on industrial giants like Emerson Electric. Investors will be observing future adjustments to Aberdeen Group's position to gauge market sentiment and the company's long-term prospects.
Humana, Inc. Experiences Valuation Adjustment Amidst Competitive Healthcare Market Dynamics
Humana, Inc. has seen a valuation adjustment, with its stock currently priced at $176.95. The company's stock return has declined by 33.16% over the past year, contrasting with the S&P 500's 16.73% increase. Despite this, Humana maintains a premium market positioning relative to peers like Centene Corp., indicating competitive dynamics within the healthcare services sector.
Fair Isaac Corp (FICO) Stock Price, Quote, News & History
This Benzinga page provides a comprehensive overview of Fair Isaac Corp (FICO) stock, including its current price, historical data, news, key statistics, and financial metrics. It also features analyst trends and forecasts, valuation metrics, company debt information, and answers to frequently asked questions about buying FICO stock, its competitors, and price targets.
Molina Healthcare, Inc. (MOH) stock price, news, quote and history
This page provides comprehensive information on Molina Healthcare, Inc. (MOH) stock, including its current price, historical data, financial performance, and analyst ratings. The stock closed at $134.03, down 3.44%, with recent news highlighting its Q4 earnings, a 55% one-year share price fall, and a new position by billionaire Seth Klarman. The company operates in healthcare plans, primarily serving low-income families through Medicaid, Medicare, and state insurance marketplaces.
Centene Corp. stock outperforms competitors on strong trading day
Centene Corp. (CNC) saw its stock rise by 3.42% to $35.11 on Thursday, marking its third consecutive day of gains. This performance occurred on a mixed trading day, with the S&P 500 Index closing up 0.11% and the Dow Jones Industrial Average falling 0.13%. The article highlights Centene's strong individual stock performance against its competitors.
One North Carolina health plan for 980,000 members, no benefit changes
Centene units Carolina Complete Health and WellCare of North Carolina have merged and will operate under the Carolina Complete Health brand. The combined entity will serve over 980,000 members across Medicaid, Medicare, and the Marketplace, including 240,000 Behavioral Health and I/DD Tailored Plan members. This merger will not result in any changes to member benefits or provider access and aims to strengthen a provider-led model focusing on coordinated care and improved health outcomes.
HF Advisory Group LLC Increases Stock Position in Elevance Health, Inc. $ELV
HF Advisory Group LLC significantly increased its stake in Elevance Health (NYSE: ELV) by 1,797% in Q4, acquiring an additional 144,655 shares to hold a total of 152,705 shares valued at approximately $53.53 million, making it their 7th largest holding. This comes as Elevance Health exceeded Q4 EPS estimates with strong revenue growth, raised its quarterly dividend, and maintains a "Moderate Buy" analyst rating. The company also reported solid financial metrics including a market cap of $65.68 billion and a P/E ratio of 11.90.
Cigna posts Q1 results by 6:30 a.m. ET, holds investor call April 30
The Cigna Group (NYSE: CI) announced it will release its first quarter 2026 financial results on April 30, 2026, by 6:30 a.m. ET. Management will host a conference call to discuss these results at 8:30 a.m. ET, with a live webcast and replay available. This announcement continues the company's established practice of pre-announcing earnings logistics, with historical data showing an average -5.52% stock move following previous earnings-tagged events, despite often positive fundamentals.
Centene's Q1 2026 Earnings: What to Expect
Centene Corporation is expected to announce its Q1 2026 earnings on April 28th, with analysts predicting a profit of $1.88 per share, a significant drop from the previous year. Despite underperforming the S&P 500 and the healthcare sector, the company beat Q4 revenue estimates. Analysts currently have a "Hold" rating on CNC stock, with a potential upside of 28.9% from current levels.
Centene's Q1 2026 Earnings: What to Expect
Centene Corporation (CNC) is expected to announce its Q1 2026 earnings before market open on April 28, 2026. Analysts project a diluted profit of $1.88 per share, a drop of 35.2% year-over-year. Despite beating revenue forecasts in Q4, CNC stock has significantly underperformed the S&P 500 and the Health Care Select Sector SPDR ETF over the past year, with analysts generally holding a "Hold" rating.
Health Insurance Providers Stocks Q4 Recap: Benchmarking UnitedHealth (NYSE:UNH)
This article provides a Q4 recap for health insurance providers, benchmarking UnitedHealth (NYSE:UNH) against its peers. It details the financial performance, revenue beats and misses, and stock reactions for UnitedHealth, Clover Health (CLOV), Molina Healthcare (MOH), Centene (CNC), and Oscar Health (OSCR). The report highlights Clover Health as having the best Q4 performance relative to analyst estimates and Molina Healthcare as the weakest.
Centene Corp. stock outperforms competitors on strong trading day
Centene Corp. (CNC) saw its stock rise by 3.70% on Wednesday, closing at $33.95. This performance outpaced the broader market, with both the S&P 500 Index and the Dow Jones Industrial Average also ending the day higher. It marked the second consecutive day of gains for the company's stock.
UBS Autocallable Notes Linked to Centene (AMUB) — $1,000 Notes, 17.21% Coupon
UBS is offering Trigger Autocallable Contingent Yield Notes with Memory Interest linked to Centene Corporation stock, totaling $550,000, with each Note having a principal of $1,000 and a 17.21% per annum contingent coupon. These Notes feature automatic early calling if Centene's stock reaches a specific threshold and a memory feature for unpaid coupons, but expose investors to full downside risk and issuer credit risk if not called. The estimated initial value of the Notes was $959.40, below the issue price, highlighting the inherent costs and risks associated with this complex structured product.
Leerink sees UnitedHealth stock facing largest RADV audit exposure
Leerink's report indicates that the Centers for Medicare & Medicaid Services (CMS) is significantly expanding its 2020 Risk Adjustment Data Validation (RADV) audits, reviewing 470 Medicare Advantage contracts compared to 58 in 2018. UnitedHealth Group (NYSE:UNH) faces the most substantial exposure, with 60 contracts covering 92% of its 2020 Medicare Advantage membership under review. All publicly traded Medicare Advantage plans are included in these expanded audits, which will begin processing in April 2025.
Rockland Trust Co. Purchases 63,538 Shares of Elevance Health, Inc. $ELV
Rockland Trust Co. significantly increased its stake in Elevance Health (NYSE:ELV) by 8,251.7%, purchasing 63,538 shares to bring its total holdings to 64,308 shares, valued at approximately $22.54 million. This move comes as Elevance Health reported Q4 EPS of $3.33, exceeding analyst expectations, and projected FY 2026 guidance at $25.50 EPS. The company maintains a "Moderate Buy" consensus rating from analysts with an average target price of $387.40, and also recently increased its quarterly dividend to $1.72 per share.
Form DEF 14A ENTERPRISE FINANCIAL For: Mar 31
This DEF 14A filing by Enterprise Financial Services Corp (EFSC) outlines the proposals for its 2026 Annual Meeting of Stockholders, including the election of 12 directors, ratification of Deloitte & Touche LLP as the independent auditor, and an advisory vote on executive compensation. The document details the company's executive compensation philosophy, which emphasizes performance-based incentives aligned with stockholder value, and provides a comparative analysis of pay versus performance. It also includes information on director compensation, committee structures, and beneficial ownership.
Cyber Threats - CareCloud reports data breach after cyberattack disrupts EHR system
CareCloud Inc., a New Jersey-based healthcare IT company, has reported a data breach following a cyberattack on March 16. The attack disrupted one of its electronic health record systems, leading to the exposure of sensitive patient data.
JPMorgan Cuts PT on Centene Corporation (CNC) to $41 From $45 – Here’s Why
JPMorgan has reduced its price target on Centene Corporation (CNC) to $41 from $45, reiterating a Neutral rating, due to near-term uncertainty in Managed Medicaid and potential Affordable Care Act enrollment contraction. Separately, Mizuho also lowered its price target to $41 from $47 following the company's fiscal Q4 report and comments at a competitor's conference, citing a more conservative valuation multiple. Centene, a healthcare enterprise in government-sponsored programs, saw its stock sell off by 16% in the past week.
Flournoy Development buys 51 acres from Centene with plans to immediately start project
Flournoy Development Group purchased nearly 52 acres in University Research Park from Centene Corp. on March 27 for $11 million. The Georgia developer plans to immediately break ground on a two-phase, 318-unit apartment community at 10200 Claude Freeman Drive. This site was previously designated for a large corporate campus.
Enhabit (EHAB) deal: $13.80 cash takeover backed by Kinderhook ($688M equity)
Enhabit, Inc. is being acquired by Anchor Parent, LLC, an affiliate of Kinderhook Industries, for $13.80 per share in cash, representing a 33.8% premium to its 60-day volume-weighted average price through February 20, 2026. Kinderhook-affiliated funds are committing $688 million in equity to fund the $690.4 million transaction, which is unanimously recommended by Enhabit's Board of Directors. The deal will result in Enhabit becoming a private company, delisting its stock from the NYSE, and ceasing SEC filings.
HCA Healthcare Inc Stock: Stable Leader in U.S. Hospital Operations Amid Healthcare Sector Shifts
HCA Healthcare Inc (ISIN: US42225T1079) is a leading U.S. hospital operator, known for its extensive network and focus on acute care. The company navigates the healthcare sector through operational efficiency, strategic acquisitions, and a strong market position, benefiting from demographic tailwinds and consistent financial performance. While facing regulatory and labor challenges, HCA remains a stable investment for North American portfolios seeking exposure to essential healthcare infrastructure.
Molina Healthcare, Inc $MOH Holdings Raised by SG Americas Securities LLC
SG Americas Securities LLC significantly increased its stake in Molina Healthcare (NYSE:MOH) by 923.3% in the fourth quarter of the previous year, now owning 87,220 shares worth approximately $15.14 million. This comes despite Molina Healthcare reporting a substantial earnings per share miss for its last quarter, though revenue exceeded expectations. The stock is currently trading below its 50- and 200-day moving averages, with analysts maintaining a consensus "Hold" rating and an average price target of $169.21.
Elevance Health, Inc. $ELV Holdings Lifted by Exchange Traded Concepts LLC
Exchange Traded Concepts LLC significantly increased its stake in Elevance Health (ELV) by 58.7%, alongside other major institutional investors, pushing total institutional ownership to 89.24%. Analysts maintain a "Moderate Buy" consensus with a $387.40 target, despite recent price target trims. Elevance Health reported strong Q4 earnings, beating EPS estimates and increasing its quarterly dividend to $1.72, signaling robust operational and financial health.
Centene’s Community Grants Reflect Dedication to Its Mission Despite a 45% Drop in Shares—A Strategic Move to Protect Reputation at Minimal Cost?
Centene is continuing its community grant programs despite a significant 45% drop in its stock price over the past year. These localized initiatives, which address non-medical challenges and social determinants of health with relatively modest financial commitments, are seen as a strategic move to protect the company's reputation and signal its commitment to its mission during financial turbulence. While the grants offer reputational benefits and long-term stakeholder engagement, they do not directly address Centene's underlying financial struggles, raising questions for investors about the balance between community investment and operational priorities.
$500,000 in Delaware grants targets housing, transportation
Delaware First Health and the Centene Foundation have opened a grant program totaling $500,000 over three years for Delaware-based 501(c)(3) organizations serving Medicaid populations. Applications are due May 25, 2026, with priority given to projects addressing housing instability or transportation accessibility. This initiative aims to address social drivers of health and improve the well-being of Delawareans.
Delaware First Health and the Centene Foundation Announce Grant Program Open Submission Period
Delaware First Health and the Centene Foundation have opened a grant program for non-profit, community-based organizations in Delaware to address social determinants of health. Grants totaling $500,000 will be awarded over three years, with a minimum of $10,000 per grant, focusing on housing instability and transportation accessibility. Applications are due by May 25, 2026, and must demonstrate impact and serve the Medicaid population.
Delaware First Health and the Centene Foundation Announce Grant Program Open Submission Period
Delaware First Health and the Centene Foundation have announced an open submission period for a grant program aimed at addressing social determinants of health in Delaware. Non-profit, community-based organizations and providers can apply for a share of $500,000 in funding to tackle issues like housing insecurity and transportation accessibility. Applications are due by May 25, 2026, with awards announced in September, and preference will be given to proposals focusing on housing instability or transportation.
Elevance Health (NYSE: ELV) 2026 proxy outlines 2025 growth, pay and ESG
Elevance Health's 2026 proxy statement details robust 2025 financial performance, including $197.6 billion in operating revenue and $6.8 billion in adjusted net income, alongside returning $4.1 billion to shareholders. The company emphasizes its whole health strategy, strong governance with independent board oversight, and commitments to ESG initiatives, including AI governance, fair pay, and environmental sustainability. Shareholders will vote on director elections, executive compensation, auditor ratification, and a proposal regarding corporate political contributions at the virtual annual meeting on May 13, 2026.
Carolina Complete Health and Centene Foundation Announce Investment and Groundbreaking of Major Affordable Housing Initiative in Northeast Winston-Salem with McCormack Baron Salazar
Carolina Complete Health and the Centene Foundation, in collaboration with McCormack Baron Salazar, have announced a significant investment and groundbreaking for Phases 2 and 3 of the Northeast Winston-Salem Choice Neighborhood Initiative. This $2 million investment will support the rebuilding of 244 housing units and provide essential health services, workforce development, and family support to residents. The initiative aims to address social drivers of health and foster long-term well-being in the community.
Centene Corp. stock underperforms Friday when compared to competitors
Centene Corp. (CNC) shares fell 4.65% on Friday, closing at $32.00, significantly underperforming the broader market. This drop occurred during a rough trading session where the S&P 500 Index and Dow Jones Industrial Average also experienced notable declines. The company's stock is now 51.54% below its 52-week high of $66.03, achieved on April 8th.
